For a private company like DeepSeek, valuation is usually a matter of whispers and secondary trades. But two Chinese listed companies have just given investors a rare public price tag: about 351 billion yuan ($52 billion), according to Reuters.
That number comes from fund investment disclosures filed by Anhui Korrun, a China-listed materials firm, and Jiuan Medical. The filings offer a glimpse into the value of DeepSeek, a Hangzhou-based private AI startup that has been spending heavily to stay competitive in the fast-moving artificial intelligence space.
How the valuation emerged
Anhui Korrun disclosed that a fund it backed bought an indirect 0.8265% stake in DeepSeek. That stake works out to an implied valuation of roughly 350.88 billion yuan. Jiuan Medical separately disclosed a fund investment that Reuters said broadly lines up with that figure.
There is a catch: the filings do not clearly state whether the funds bought newly issued shares, existing shares, or securities with different rights. That means the implied valuation is more of a “transaction-implied” number than a clean, official round price. Still, for a private company that keeps its fundraising terms quiet, it is one of the few public data points available.
DeepSeek is not alone in facing this kind of uncertainty. Many private AI startups keep their valuations opaque, making any credible public price a potential reference point for investors. The 351 billion yuan mark now acts like a de facto “last price” for DeepSeek, even with the ambiguity around what was purchased.
What it means for investors
For everyday investors, this matters because reference points shape expectations. If DeepSeek does raise up to 50 billion yuan at roughly 500 billion yuan, as Reuters reported the company is considering, that higher figure will be judged against the 351 billion yuan baseline. And if DeepSeek moves toward a Shanghai STAR Market listing, bankers and investors often triangulate early IPO price ranges off the most recent private marks.
That process can influence how other China AI deals get priced on the path from private funding to public markets. The STAR Market, China’s tech-focused board, has seen a mix of high-profile listings and some that have fizzled. For example, the Digi Spain IPO pop fizzled as shares slipped back to their offer price, a reminder that public market reception can be unpredictable.
DeepSeek is reportedly spending heavily to stay competitive in AI, where chips, data centers, and top engineers are expensive. That spending is a key reason the company may need to raise more capital. The reported new round of up to 50 billion yuan at about a 500 billion yuan valuation would be a significant step up from the current implied figure.
Broader market context
The AI sector has been a major driver of market attention, with companies like Publicis raising growth targets on AI marketing demand and Csquare pricing a $1.05 billion IPO as an AI infrastructure bet. But the sector is not without risks. European stocks stalled recently as AI optimism clashed with oil price jitters, showing how broader market forces can affect even the most hyped sectors.
For DeepSeek, the path to a public listing is still uncertain. The company has reportedly started early work toward a potential Shanghai STAR Market IPO, with an internal goal to file this year. But the timeline and final valuation will depend on market conditions, regulatory approvals, and the company’s ability to demonstrate sustainable growth.
Investors should watch for any further disclosures from the funds involved, as well as any official announcement from DeepSeek about a new fundraising round. The 351 billion yuan mark is a starting point, not a final answer.
